Influence of Cardiac Risk Factors and Medication on Length of Hospitalization in Patients Undergoing Major Vascular Surgery

American Journal of Cardiology

Volumn 97, Issue 10, 2006, Pages 1423-1426

  van de Pol, Marleen A ^a   van Houdenhoven, Mark ^a   Hans, Erwin W ^b   Boersma, Eric ^c   Bax, Jeroen J ^a   Feringa, Harm H H ^a   Schouten, Olaf ^a   van Sambeek, Marc R H M ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION MODEL; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VASCULAR SURGERY;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; ASPIRIN; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 33646168143     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.032     Document Type: Article

References (18)

1. Macario A., Vitez T.S., Dunn B., and McDonald T. Where are the costs in perioperative care? Analysis of hospital costs and charges for inpatient surgical care. Anesthesiology 83 (1995) 1138-1144
2. Chang J.K., Calligaro K.D., Lombardi J.P., and Dougherty M.J. Factors that predict prolonged length of stay after aortic surgery. J Vasc Surg 38 (2003) 335-339
3. Collins T.C., Daley J., Henderson W.H., and Khuri S.F. Risk factors for prolonged length of stay after major elective surgery. Ann Surg 230 (1999) 251-259
4. Kazmers A., Jacobs L., and Perkins A. The impact of complications after vascular surgery in Veterans Affairs medical centers. J Surg Res 67 (1997) 62-66
5. Kertai M.D., Klein J., van Urk H., Bax J.J., and Poldermans D. Cardiac complications after major vascular surgery. Acta Anaesthesiol Scand 47 (2003) 643-654
6. Bartholomew B.A., Harjai K.J., Grines C.L., Boura J.A., Grines L.L., Stone G.W., Cox D.A., Brodie B.R., and O'Neill W.W. Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic related group system. Am J Cardiol 92 (2003) 830-833
7. Mangano D.T., and Goldman L. Preoperative risk assessment of patients with known or suspected coronary disease. N Engl J Med 333 (1995) 1750-1758
8. Kertai M.D., Boersma E., Westerhout C.M., Klein J., van Urk H., Bax J.J., Roelandt J.R.T.C., and Poldermans D. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28 (2004) 343-352
9. Kertai M.D., Boersma E., Klein J., van Sambeek M., Schouten O., van Urk H., and Poldermans D. Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model. Arch Intern Med 165 (2005) 898-904
10. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., Thomson I.R., Lansberg P.J., Fleisher L.A., Klein J., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac surgery. Circulation 107 (2003) 1848-1851
11. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P.A., and Danias P.G. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vacular surgery. J Am Coll Cardiol 45 (2005) 335-342
12. Durazzo A.E.S., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leão P., and Caramelli B. Reduction in cardiovascular events after vascular surgery with atorvastatin. a randomised trial. J Vasc Surg 39 (2004) 967-976
13. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., Baars H.F., Yo T.I., Trocino G., Vigna C., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
14. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335 (1996) 1713-1720
15. Auerbach A.D., and Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery. JAMA 287 (2002) 1435-1444
16. POBBLE Trial Investigators. Perioperatible Beta-Blockade (POBBLE) for patients undergoing infrarenal vascular surgery. results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
17. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schets M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 19 (2001) 1359-1367
18. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 (2004) 1187-1195